Summary
A POPULAR slimming drug widely available in the UK is being investigated for links to liver damage.
The US Food and Drug Administration (FA) announced yesterday it is reviewing complaints reported by the users of the weight loss medication orlistat, which is sold as the over-the-counter drug Alli.See the full content of this document
Extract
Slimming Drug Investigated Over Liver Damage Claim
It follows more than 30 reports it has received of serious liver injury...
See the full content of this document
Sponsored links
